Challenges and opportunities for oncology drug repurposing informed by synthetic lethality. [PDF]
Vermeulen M, Craig AW, Babak T.
europepmc +1 more source
Systematic Characterization of Cancer-Associated SPOP Mutants Reveals Novel and Reprogrammable Degradative Activities. [PDF]
Caldwell AG +4 more
europepmc +1 more source
Bromodomain and Extraterminal Protein Inhibition: A Novel Therapeutic Strategy in Arthritis. [PDF]
Sheng W +5 more
europepmc +1 more source
The HYAL1 paradox in cancer: From complex tumor biology to novel therapeutic strategies. [PDF]
Jin Y, Wang T, Ma J, Quan J, Zhou N.
europepmc +1 more source
Advantages of PROTACs in achieving selective degradation of homologous protein families. [PDF]
Yang L +7 more
europepmc +1 more source
A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling. [PDF]
Lee H +12 more
europepmc +1 more source
Bromodomain and Extra-Terminal Family Proteins BRD2, BRD3, and BRD4 Contribute to H19-Dependent Transcriptional Regulation of Cell Adhesion Molecules, Modulating Metastatic Dissemination Program in Prostate Cancer. [PDF]
Pecci V +12 more
europepmc +1 more source
Evaluation of Benzo[cd]indol-2(1H)-ones as Downstream Hedgehog Pathway Inhibitors. [PDF]
Tsakoumagkos IA +8 more
europepmc +1 more source

